Lens
 
International AIDS Society

Track C – Prevention Science



Epidemiology of HIV

C1 Natural history, progression and survival
C2 Trends in morbidity and mortality
C3 Measurement and modelling of the HIV epidemics
C4 Risk factors for acquisition of HIV
C5 Hormonal contraception and HIV
C6 Risk factors for infectivity, progression and transmission of HIV
C7 Epidemiology of HIV in the general population
C8 Epidemiology of HIV in children
C9 Epidemiology of HIV in youth and adolescents
C10 Epidemiology of HIV in the elderly
C11 Epidemiology of HIV in people who use drugs
C12 Epidemiology of HIV in male, female and transgender sex workers
C13 Epidemiology of HIV in MSM
C14 Epidemiology of HIV in serodiscordant couples
C15 Epidemiology of HIV in migrants
C16 Epidemiology of HIV in transgender persons
C17 Epidemiology of HIV in other populations
C18 Epidemiology of TB and HIV co-infection
C19 Epidemiology of sexually transmitted infections (STI) and HIV co-infection
C20 Epidemiology of viral hepatitis and HIV co-infection
C21 Epidemiology of other diseases and HIV co-infection
C22 Epidemiology of Serious Non-AIDS events
C23 Epidemiology of AIDS defining and non AIDS defining cancers
C24 Molecular epidemiology
C25 Geographical information systems and HIV
C26 Network studies of risk behaviours and their implications for prevention
    


HIV Surveillance

C27 Determination of HIV incidence
C28 Methods for estimating incidence using cross sectional samples
C29 HIV testing and diagnostic strategies
C30 Methods for detecting acute and recent HIV infections 
C31 Novel approaches for HIV testing
C32 Surveillance of HIV (children)
C33 Surveillance of HIV (youth and adults)
C34 Surveillance of behaviour
C35 Surveillance of HIV drug resistance (including in PrEP studies)
C36 Surveillance of opportunistic infections
C37 Surveillance systems and methods
C38 Population-based surveys with HIV testing
C39 Surveillance of Hepatitis C (HCV) and HIV co-infection
C40 Surveillance of TB and HIV co-infection
C41 Impact of HIV prevention on TB, cancers and other diseases
C42 Assessment of population viral load in epidemiology studies
C43 Modelling the epidemiological impact of large-scale prevention programmes: approaches and results
C44 Innovations in the measurement of sensitive behaviours and adherence
C45 New and novel clinical trial designs for HIV prevention (including adaptive designs)
C46 Surveillance in low incidence settings including those approaching elimination
    


Approaches and Tools for HIV Prevention

C47 STI control to prevent HIV transmission
C48 Male and female condoms and other physical barriers
C49 Male circumcision
C50 HIV testing
C51 PEP
C52 PrEP
C53 Microbicides (including vaginal and rectal microbicides)
C54 Treatment as prevention
C55 Vaccines
C56 Barriers and facilitators to adherence to biomedical HIV prevention strategies
C57 Approaches to improving adherence to prevention interventions
C58 Strategies for identifying key populations
C59 Use of the internet, social media, mobile phones and other e-devices for prevention
C60 Integration of HIV prevention services (into reproductive health and STI / care and treatment / other programmes)
C61 Biomedical measurements of adherence (including electronic devices and bioassays)
C62 Good participatory practice and community involvement in prevention research
C63 Efficacy of structural interventions and social protection
C64 Combination prevention approaches
    


Prevention of Mother-to-Child Transmission

C65 Reducing pre-partum and intra-partum transmission to infants
C66 Reducing post-partum transmission in infants
C67 Strategies to increase HIV testing in pregnant women and their partners
C68 Increasing coverage and quality of PMTCT programmes
C69 PMTCT services for marginalized groups
C70 Integration of family planning and HIV services
C71 Promoting health and reducing maternal mortality in HIV positive women
    


Population-Specific Interventions and HIV Prevention Strategies

C72 Prevention of vertical transmission
C73 Prevention for the general population
C74 Prevention for youth and adolescents
C75 Prevention for people who use drugs, including harm reduction
C76 Prevention for male, female and transgender sex workers
C77 Prevention for MSM
C78 Prevention for transgender  persons
C79 Prevention for immigrants, mobile and displaced populations
C80 Prevention for HIV serodiscordant couples
C81 Prevention for populations with multiple co-occurring epidemics / syndemics
C82 Prevention for other vulnerable populations
C83 Prevention during acute and recent infection
C84 Prevention among HIV-infected individuals
C85 Prevention in health care settings (including blood, organ and tissue safety and nosocomial transmission)
C86 Prevention in other institutional settings (including workplace / school / prison / army)
C87 Prevention addressing gender inequalities
C88 Reproductive choices and interventions for women (including discordant couples)
C89 Prevention of TB among people living with HIV
C90 Population-based intervention studies
     


Feasibility and Impact of Structural Interventions

C91 Economic-based HIV interventions (i.e., micro-capital/cash transfer/contingency management/housing/poverty reduction programmes)
C92 Assessing impact/cost-effectiveness of structural interventions
C93 Gender sensitization, empowerment and violence reduction
C94 Collectivization, mobilization, stigma reduction programmes
C95 Policy-level HIV interventions including legal-policy reform
    


Methodological Issues and Capacity-Building

C96 Research designs in epidemiology
C97 Research designs in prevention research
C98 Ethical and human rights issues in epidemiological research
C99 Ethical and human rights issues in prevention research
C100 Capacity building for epidemiological research
C101 Capacity building for HIV prevention research
C102 Community involvement in biomedical prevention
C103 Estimation of the size of HIV-infected and key populations
C104 Measurement and modelling of the impact of treatment on prevention of HIV
C105 Measurement and modelling of the impact of PrEP and microbicides
C106 Measurement and modelling of the impact of combination prevention interventions
C107 Estimation of the need for ART
C108 Estimation of the need for PMTCT
C109 Evaluation of animal models
C110 Establishment of cohorts to study HIV incidence / preventive interventions / natural history